Targeted Enzyme Activator Drugs. Dieser Artikel ist nicht verfügbar.Targeted Enzyme Activator Drugs

Targeted Enzyme Activator Drugs For Absorbing Cancer Cells Through Neighboring Functional Cells is a scientific book that explores an innovative therapeutic concept in modern oncology. The book discusses the design and application of novel enzyme activator drugs that may enhance the ability of healthy neighboring cells to recognize, absorb, and eliminate cancer cells through biologically regulated cellular interactions. It examines the molecular pathways involved in enzyme activation, intercellular communication, targeted drug delivery, and tumor microenvironment modulation. In addition, the book reviews recent advances in cancer biotechnology, regenerative medicine, and precision therapeutics to present a multidisciplinary approach for future anticancer strategies. Intended for researchers, medical scientists, pharmacologists, and biotechnology students, this work provides both theoretical foundations and potential clinical perspectives for developing safer and more effective cancer treatments based on cellular cooperation and enzymatic regulation.

Dr. Hamed Aghazadeh is a Doctor of Pharmacy (Pharm.D.), holds a Master's degree in Pharmaceutical Engineering (M. Pharm. Eng.), an MBA in Pharma, and a Bachelor's degree in Microbiology. He is an expert in the fields of pharmaceutical sciences and cancer research.